Answers are grounded in this paper and cite their sources.
Experimental study demonstrates functional cell death induction by an auxin-activated caspase 9 system in engineered cells, indicating feasibility for multiplexed safety controls.
Engineered cells incorporating synthetic gene circuits have been developed for therapeutic and diagnostic applications. However, cell proliferation and long-term engraftment may pose a risk of unpredictable toxicities. To address this issue, a suicide switch that can be selectively activated by exogenous stimuli has been developed as a regulatory system for engineered cells. However, the variety of reliable suicide switches is limited and insufficient for the orthogonal integration of multiple functions in engineered cells. This study developed auxin-activated caspase 9 (AuxiCasp9), a novel auxin-based suicide switch, by fusing the auxin receptor protein transport inhibitor response 1 (TIR1) carrying E7K/E10K/F74A mutations and auxin protein (Aux) to caspase 9. AuxiCasp9 exhibited cell death-inducing activity comparable to that of the established systems, inducible caspase 9 (iCasp9) and rapamycin-activated caspase 9 (RapaCasp9). Finally, we confirmed the orthogonality of AuxiCasp9 and iCasp9, suggesting the feasibility of multiplexed control of engineered cells.
No takes yet. Share an insight, caveat, or question.
Yoshimoto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: